Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1B |
| 2 |
Tesla
TSLA
|
+$697M |
| 3 |
Microsoft
MSFT
|
+$447M |
| 4 |
Accenture
ACN
|
+$439M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$421M |
Top Sells
| 1 |
CRH
CRH
|
+$2.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.01B |
| 3 |
Texas Instruments
TXN
|
+$1.97B |
| 4 |
Starbucks
SBUX
|
+$1.61B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$1.07B |
Sector Composition
| 1 | Technology | 32.41% |
| 2 | Financials | 11.84% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Healthcare | 9.02% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Four Corners Property Trust
FCPT
$2.66B
| $4.57M | ﹤0.01% |
156,021
+81,565
| +110% | +$2.39M |
|
1577
Icon
ICLR
$13.6B
| $4.53M | ﹤0.01% |
15,767
+4,281
| +37% | +$1.23M |
|
1578
Enerpac Tool Group
EPAC
$2.3B
| $4.52M | ﹤0.01% |
107,979
+82,376
| +322% | +$3.45M |
|
1579
Algonquin Power & Utilities
AQN
$4.3B
| $4.52M | ﹤0.01% |
829,508
+206,603
| +33% | +$1.13M |
|
1580
WEX
WEX
$5.82B
| $4.52M | ﹤0.01% |
21,535
+5,972
| +38% | +$1.25M |
|
1581
On Holding
ONON
$14B
| $4.51M | ﹤0.01% |
90,008
+29,654
| +49% | +$1.49M |
|
1582
Petrobras
PBR
$81.4B
| $4.51M | ﹤0.01% |
313,307
-219,401
| -41% | -$3.16M |
|
1583
Banner Corp
BANR
$2.29B
| $4.51M | ﹤0.01% |
75,768
+37,390
| +97% | +$2.23M |
|
1584
Park Hotels & Resorts
PK
$2.39B
| $4.51M | ﹤0.01% |
319,593
+58,432
| +22% | +$824K |
|
1585
Interparfums
IPAR
$3.43B
| $4.49M | ﹤0.01% |
34,689
+25,862
| +293% | +$3.35M |
|
1586
Beam Therapeutics
BEAM
$2.08B
| $4.49M | ﹤0.01% |
183,214
+101,387
| +124% | +$2.48M |
|
1587
Oceaneering
OII
$2.43B
| $4.49M | ﹤0.01% |
180,470
+138,931
| +334% | +$3.46M |
|
1588
DNOW Inc
DNOW
$1.6B
| $4.48M | ﹤0.01% |
346,657
+106,927
| +45% | +$1.38M |
|
1589
Globant
GLOB
$2.47B
| $4.47M | ﹤0.01% |
22,537
+12,862
| +133% | +$2.55M |
|
1590
Apogee Enterprises
APOG
$903M
| $4.47M | ﹤0.01% |
63,769
+27,904
| +78% | +$1.95M |
|
1591
Renasant Corp
RNST
$3.68B
| $4.46M | ﹤0.01% |
137,217
+88,783
| +183% | +$2.89M |
|
1592
Astrana Health
ASTH
$1.38B
| $4.46M | ﹤0.01% |
76,916
+61,298
| +392% | +$3.55M |
|
1593
Ocular Therapeutix
OCUL
$2.23B
| $4.45M | ﹤0.01% |
511,522
+138,441
| +37% | +$1.2M |
|
1594
Franco-Nevada
FNV
$38.6B
| $4.45M | ﹤0.01% |
35,828
+8,147
| +29% | +$1.01M |
|
1595
Energizer
ENR
$2.02B
| $4.44M | ﹤0.01% |
139,890
+70,254
| +101% | +$2.23M |
|
1596
Cellebrite
CLBT
$4.11B
| $4.44M | ﹤0.01% |
263,657
+59,395
| +29% | +$1,000K |
|
1597
Celldex Therapeutics
CLDX
$1.62B
| $4.43M | ﹤0.01% |
130,381
+76,207
| +141% | +$2.59M |
|
1598
Navient
NAVI
$1.28B
| $4.43M | ﹤0.01% |
284,130
+105,454
| +59% | +$1.64M |
|
1599
Ultragenyx Pharmaceutical
RARE
$2.92B
| $4.42M | ﹤0.01% |
79,546
+16,633
| +26% | +$924K |
|
1600
Verint Systems
VRNT
$1.23B
| $4.42M | ﹤0.01% |
174,335
-73,082
| -30% | -$1.85M |
|